Provided by Tiger Trade Technology Pte. Ltd.

Loews

109.33
-0.3900-0.36%
Volume:44.14K
Turnover:4.83M
Market Cap:22.35B
PE:13.40
High:109.60
Open:109.51
Low:109.16
Close:109.72
52wk High:121.01
52wk Low:95.10
Shares:204.43M
Float Shares:164.40M
Volume Ratio:0.34
T/O Rate:0.03%
Dividend:0.25
Dividend Rate:0.23%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.17
PE(LYR):13.71

Loading ...

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

GlobeNewswire
·
Jul 22

Loews Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 17

CNA Financial to Report Q2 2026 Results Before Market Open

Reuters
·
Jul 14

Loews Schedules Second-quarter Results Release

Reuters
·
Jul 14

Oracle Expands Loews Hotels Rollout of OPERA Cloud Central Services

Reuters
·
Jul 14

As Europe bakes, Eurostar orders trains that can cope with 131 degree heat

CNN Business
·
Jul 10

Loews Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Loews Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

3 Reasons Loews (L) Looks Close To Fair Value After Its Move To $113.25

Simply Wall St.
·
Jun 27

The lifeline saving regional mums through a computer and their internet connection‘The reality is, 25 per cent of parents are experiencing symptoms and they just don’t know who to reach out to, where to go, what to do.’4 min read

7NEWS
·
Jun 26

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

GlobeNewswire
·
Jun 25

Loews Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Why can’t Britain hold on to prime ministers? It’s the economy

CNN Business
·
Jun 23

Loews (L) Stock After 5-Year 102% Return Is The Current Price Justified

Simply Wall St.
·
Jun 16

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

GlobeNewswire
·
Jun 11

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

Stock News
·
Jun 11

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 11

Loews sets final BDR dividend at BRL 0.22 per share

Reuters
·
Jun 11

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

GlobeNewswire
·
Jun 10